PCA
ELI

Personal Capital Advisors’s ELITE PHARMACEUTICAL ELI Stock Holding History

Personal Capital Advisors’s Portfolio ELI Stock Details ELI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-25,000
Closed -$4K – 184
2016
Q3 		$4K Hold
25,000
– – ﹤0.01% 174
2016
Q2 		$8K Hold
25,000
– – ﹤0.01% 167
2016
Q1 		$8K Hold
25,000
– – ﹤0.01% 160
2015
Q4 		$10K Hold
25,000
– – ﹤0.01% 158
2015
Q3 		$6K Buy
+25,000
New +$6K ﹤0.01% 148

Other funds holding ELI

GA
Geneva Advisors Chicago, Illinois $5.81B AUM 23.71% 1-Year Est. Return
JAFL
Jay A. Fishman Ltd Troy, Michigan $1.26B AUM 31.39% 1-Year Est. Return
SBL
Sargent Bickham Lagudis Boulder, Colorado $1.22B AUM 14.94% 1-Year Est. Return

Personal Capital Advisors's ELI Position: Q4 2016 in Review

Personal Capital Advisors sold out of ELITE PHARMACEUTICAL (ELI) in Q4 2016, closing a stake of 25,000 shares — an estimated $4K sold.

Personal Capital Advisors first reported a position in ELI in Q3 2015 and held it in 5 quarters. The position peaked at $10K in Q4 2015. 3 funds tracked by Wall St. Rank hold ELI as of Q4 2016.

  • Personal Capital Advisors reported no remaining ELITE PHARMACEUTICAL position as of Q4 2016 after selling out during the quarter.
  • Personal Capital Advisors sold 25,000 ELITE PHARMACEUTICAL shares in Q4 2016, an estimated $4K.
  • Personal Capital Advisors first reported a position in ELITE PHARMACEUTICAL in Q3 2015 and held it in 5 quarters.
  • Personal Capital Advisors's ELITE PHARMACEUTICAL position peaked at $10K in Q4 2015.
  • 3 funds tracked by Wall St. Rank held ELITE PHARMACEUTICAL as of Q4 2016.

Based on Personal Capital Advisors's 13F filing for Q4 2016, filed 24 Jan 2017.